Bal Pharma
₹91.2
-3.95 (-4.15%)
28 March, 2024 16:54 BSE: 524824
NSE: BALPHARMAISIN: INE083D01012
Start SIP in Bal Pharma
Start SIPBal Pharma Performance
Day Range
- Low 90
- High 97
52 Week Range
- Low 63
- High 132
- Open Price95
- Previous Close95
- Volume46752
Bal Pharma Financials
Indicator | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|
Oper Rev Qtr Cr | 81 | 92 | 70 | 82 |
Operating Expenses Qtr Cr | 74 | 85 | 63 | 74 |
Operating Profit Qtr Cr | 8 | 8 | 7 | 8 |
Depreciation Qtr Cr | 3 | 2 | 2 | 2 |
Interest Qtr Cr | 4 | 4 | 4 | 4 |
Tax Qtr Cr | 0 | 1 | 0 | 1 |
Net Profit Qtr Cr | 1 | 2 | 1 | 2 |
Bal Pharma Technicals
EMA & SMA
Current Price
₹91.2
-3.95 (-4.15%)
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 16
- 20 Day
- ₹101.70
- 50 Day
- ₹106.97
- 100 Day
- ₹106.33
- 200 Day
- ₹101.98
- 20 Day
- ₹102.21
- 50 Day
- ₹112.15
- 100 Day
- ₹108.34
- 200 Day
- ₹100.83
Bal Pharma Resistance and Support
PIVOT
₹96.34
Resistance | |
---|---|
First Resistance | 97.67 |
Second Resistance | 100.18 |
Third Resistance | 101.52 |
RSI | 36.77 |
MFI | 49.48 |
MACD Single Line | -4.90 |
MACD | -4.89 |
Support | |
---|---|
First Resistance | 93.82 |
Second Resistance | 92.48 |
Third Resistance | 89.97 |
Bal Pharma Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 28,147 | 2,109,899 | 74.96 |
Week | 34,175 | 2,549,778 | 74.61 |
1 Month | 26,638 | 1,774,332 | 66.61 |
6 Month | 81,363 | 4,393,609 | 54 |
Bal Pharma Result Highlights
Bal Pharma Synopsis
NSE-Medical-Diversified
Bal Pharma Ltd belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 303.10 Cr. and Equity Capital is Rs. 15.69 Cr. for the Year ended 31/03/2023. Bal Pharma Ltd. is a Public Limited Listed company incorporated on 19/05/1987 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L85110KA1987PLC008368 and registration number is 008368.Market Cap | 150 |
Sales | 326 |
Shares in Float | 0.77 |
No of funds | 1 |
Yield | 1.05 |
Book Value | 1.55 |
U/D Vol ratio | 1.3 |
LTDebt / Equity | 32 |
Alpha | -0.01 |
Beta | 1.46 |
Bal Pharma
Owner Name | Dec-23 | Sep-23 | Jun-23 | Mar-23 |
---|---|---|---|---|
Promoters | 51.23% | 51.61% | 51.61% | 51.61% |
Foreign Portfolio Investors | 0.13% | 0.14% | 0.17% | 0.17% |
Individual Investors | 32.64% | 32.19% | 31.99% | 32.07% |
Others | 16% | 16.06% | 16.23% | 16.15% |
Bal Pharma Management
Name | Designation |
---|---|
Mr. Shailesh D Siroya | Managing Director |
Mr. Himesh Virupakshaya | Executive Director |
Mr. Jatish Sheth | Independent Director |
Dr. C V Srinivas | Independent Director |
Ms. Nicloa Neeladri | Independent Director |
Mr. H S Venkatesh | Independent Director |
Mr. Kotian Chittananda Damodar | Executive Director |
Bal Pharma Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Bal Pharma Corporate Action
Date | Purpose | Remarks |
---|---|---|
2024-02-12 | Quarterly Results | |
2023-11-08 | Quarterly Results & ESOP | |
2023-08-11 | Quarterly Results & A.G.M. | |
2023-05-29 | Audited Results & Final Dividend | |
2023-02-06 | Quarterly Results |
Bal Pharma FAQs
What is Share Price of Bal Pharma ?
Bal Pharma share price is ₹91 As on 28 March, 2024 | 16:40
What is the Market Cap of Bal Pharma ?
The Market Cap of Bal Pharma is ₹144.1 Cr As on 28 March, 2024 | 16:40
What is the P/E ratio of Bal Pharma ?
The P/E ratio of Bal Pharma is 41 As on 28 March, 2024 | 16:40
What is the PB ratio of Bal Pharma ?
The PB ratio of Bal Pharma is 2.3 As on 28 March, 2024 | 16:40